rs780991031
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 16P and 1B. PVS1PP5_Very_StrongBS2_Supporting
The NM_182961.4(SYNE1):c.9625A>T(p.Lys3209Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_182961.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNE1 | NM_182961.4 | c.9625A>T | p.Lys3209Ter | stop_gained | 60/146 | ENST00000367255.10 | NP_892006.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNE1 | ENST00000367255.10 | c.9625A>T | p.Lys3209Ter | stop_gained | 60/146 | 1 | NM_182961.4 | ENSP00000356224 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251442Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135900
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727242
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74326
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Mar 08, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 19, 2023 | This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features of cerebellar ataxia. In some published literature, this variant is referred to as c.9646A>T p.K3216*. - |
Cerebellar ataxia;C1853116:Autosomal recessive ataxia, Beauce type Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fundacion Diagnosis | Jun 05, 2019 | Regarding to the variant found in the patient in our case, it is a homozygous mutation in the SYNE1 gene (c.9625A> T p.Lys3209Ter) that generates a substitution of a thymine for an adenine at position 9625 resulting in the generation of a premature termination codon. Different studies have analyzed families with truncating and frameshift mutations, demonstrating that both result in a process of "nonsense-mediated mRNA decay" (4), consistent with a loss of protein function and are related to SCAR8, therefore they are considered pathogenic. In our case, our variant is not previously described in the literature, so studies of other families with this variant and / or specific functional evaluation are necessary to definitively classify it as pathogenic. (SYNOFZIK 2016). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at